Welcome to the German Accelerator Life Sciences Application

Thank you for your interest in applying to the German Accelerator Life Sciences program.

Our application consists of around 20 questions about your company, team, technology, and business plan. We also request that companies submit additional materials with their application, such as a slide deck and a product demo (if available). Questions marked with an asterisk (*) are required answers.

Applicants must be promising emerging life science companies that have great potential to benefit from the German Accelerator Life Sciences program. Companies must have an affiliation with Germany, i.e. incorporated in Germany or with significant operations there. Applicants must develop a product or service in (at least) one of the five supported life science segments: Digital Health, Medical Devices, Diagnostics, Therapeutics, or Platform Technologies.

For more information on our program or application process, please visit our website (www.GermanAccelerator.com/life-sciences) or email your question to: gals@germanaccelerator.com

General Information

Question Title

* 1. Company Name

Question Title

* 2. Company Website

Question Title

* 3. Name of Contact Person

Question Title

* 4. Company Location(s) - If multiple, please describe.

Question Title

* 5. Email of Contact Person

Question Title

* 6. When and where did you incorporate your company and what is its current legal status?

Question Title

* 7. Identify the primary life science segment your company operates in.

Question Title

* 8. How did you hear about German Accelerator Life Sciences?

Summary

Question Title

* 9. Please provide a brief executive summary of your company (max. 50 words)

Product - Value Proposition
(If feasible, please include a product demo in the Additional Materials section, or arrange to give a product demo if your product is an app.)

Question Title

* 10. Breakthrough for Patients - What is the problem to solve and/or the unmet medical need? How is it currently (not) addressed? How do you solve it? What is the value proposition?

Question Title

* 11. Technology (POS) - Briefly describe the technology behind the product (features, architecture) including the current stage of product development and your future roadmap.

Question Title

* 12. Clinical Doability - How did you demonstrate the technical and clinical Proof of Concept? Or how do you plan to?

Question Title

* 13. Intellectual Property - How is the product protected? – To what extend do you have freedom to operate?

Question Title

* 14. Regulatory Path - Do you have or are you seeking FDA approval? Have you obtained any other certification (e.g., CE Mark, EMA)?

Value Creation - Commercial Opportunity

Question Title

* 15. Value Creation Curve – What is your Target Product/ Service Profile? How do you create value (for patients, the investor, the company)? How scalable is the product/service?

Question Title

* 16. Commercial Doability/ Marketing and Sales – Outline who your customers are and how you target them. Include geography, differences in profitability and pricing, and key drivers for purchase decisions for each customer type.

Question Title

* 17. Reimbursement – What is the reimbursement/ revenue strategy? Who will pay for the product?

Question Title

* 18. Sweet Spot – List direct and indirect competitors (companies and technologies that use other approaches but yield parallel results) and disruptive technologies, approaches and/or trends if any. How do you differentiate yourself?

Question Title

* 19. Partnering Opportunity - How do you foresee the future of your company? Where do you see potential partnering/ licensing options? Do you have a desired exit strategy for the business? What is the proposed timeframe?

Question Title

* 20. Operations – What is your anticipated path forward, including timeline, milestones and resource requirements? What are the risks and challenges your company faces? Where are your opportunities for growth and improvement? What overall goals do you want to achieve by entering the U.S.? Why now? What would be the downside if you do not enter the U.S. market?

Financing

Question Title

* 21. Financing – Annual financials (past, current, future) including revenue, costs (itemized list). What is your current burn rate?

Question Title

* 22. Funding – How much money have you raised and from whom? Please describe the ownership structure of your company (including %). Did you receive de-minimis support in the last 2 fiscal years according to (EU) Nr. 1407/2013 and if so how much?

Team

Question Title

* 23. Team – Tell us about the team’s background and strengths. Describe the role and include a brief bio of each team member (founders, management leadership team, board members, advisors). How many FTEs do you have? What additional team members do you need to recruit?

GALS Impact

Question Title

* 24. GALS Impact - Please describe how your company could benefit from German Accelerator Life Sciences support. What are specific milestones you want to reach in the program?

Question Title

* 25. External Help - Are you participating now, or have you ever participated in any other accelerator/incubator programs? If so, briefly describe the program and the support you have received, and the (expected) start and end dates.

Additional Materials

Question Title

* 26. Additional Materials: Company Slide Deck

Please submit or provide a link to your company's non-confidential slide deck.

DOCX, DOC, JPEG, GIF, JPG, PDF, PNG file types only.
Choose File
No file chosen

Question Title

* 27. Additional Materials: Other

Please submit or provide a link to your company's pitch video, product demo, and/or any additional materials.

DOCX, DOC, JPEG, GIF, JPG, PDF, PNG file types only.
Choose File
No file chosen

Question Title

* 28. Additional Materials: Other

Please submit or provide a link to your company's pitch video, product demo, and/or any additional materials.

DOCX, DOC, JPEG, GIF, JPG, PDF, PNG file types only.
Choose File
No file chosen
Consent

Question Title

* 29. Consent to Sharing of Data and Other Information

By submitting this application, you acknowledge and agree that that the data and other information you provide in connection with this application, including any files you have uploaded or otherwise submitted to the German Accelerator Life Sciences (GALS), may be shared by GALS with GALS' selection committee and GALS' advisors in connection with evaluating your application for the program and in connection with your participation. GALS may also share the information entered under "A) Company Overview" and "Upload 1: NON-CONFIDENTIAL SLIDE DECK" with its strategic partners. Any information you provide in connection with this application is subject to the terms of our Privacy Policy: www.germanaccelerator.com/privacy-policy/. Please note that we have no control over and are not liable for SurveyMonkey's use of any information you provide, and we encourage you to read its privacy policy at: https://www.surveymonkey.com/mp/policy/privacy-policy/

T